Stay updated on TAK-659 in AML Clinical Trial
Sign up to get notified when there's something new on the TAK-659 in AML Clinical Trial page.

Latest updates to the TAK-659 in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded revision tag v3.4.2 and removed the previous v3.4.1 notice; these are minor updates that do not alter trial details.SummaryDifference0.3%

- Check20 days agoChange DetectedAdded a government funding lapse notice with links to cc.nih.gov and opm.gov, and updated the site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

- Check28 days agoChange DetectedShow glossary toggle added; QC labels adjusted (Last Update Submitted that Met QC Criteria) and No FEAR Act data wording updated; footer revision indicator updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page's revision history was updated with a new entry Revision: v3.3.4 and the prior Revision: v3.3.3 was removed, indicating a minor log update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedA single 'Locations' section lists all study sites (Alabama, Illinois, Maryland, Massachusetts, Michigan, Minnesota, New York, North Carolina, Ohio, Texas, Wisconsin, Nova Scotia, Ontario) under one heading, replacing the prior separate location entries. The revision label updated to v3.3.3.SummaryDifference1%

- Check92 days agoChange DetectedThe Publications note now states that PubMed auto-fills publications and may not be about the study, and the Revision tag has been updated to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to TAK-659 in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-659 in AML Clinical Trial page.